A meta-analysis of interleukin-10-1082 promoter genetic polymorphism associated with atherosclerotic risk

Neurology India

Volumn 62, Issue 2, 2014, Pages 130-136

  Chao, Li ^a   Lei, Huang ^a   Fei, Jin ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; gene; interleukin 10; meta analysis; single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 10;

ARTICLE; ASIA; ATHEROSCLEROSIS; CAUCASIAN; CEREBROVASCULAR ACCIDENT; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK;

EID: 84901445045     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.132323     Document Type: Article

References (26)

1. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915-24.
2. Uyemura K, Demer LL, Castle SC, Jullien D, Berliner JA, Gately MK, et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 1996;97:2130-8. (Pubitemid 26143968)
3. Wang Y, Zheng J, Liu P, Yu X, Zhou D, Jiang L, et al. Association between the Interleukin 10-1082G>A polymorphism and coronary heart disease risk in a Caucasian population: A meta-Analysis. Int J Immunogenet 2012;39:144-50.
4. Wells G, Shea B, O'connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-Analyses. Ottawa Health Research Institute. Available from: Http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. [Last accessed on 2011 Oct 20].
5. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for meta-Analysis. Stat Med 1995;14:395-411.
6. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-Analyses. BMJ 2003;327:557-60. (Pubitemid 37088507)
7. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
8. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-Analysis of molecular association studies. Stat Med 2005;24:1291-306. (Pubitemid 40585169)
9. Bown MJ, Burton PR, Horsburgh T, Nicholson ML, Bell PR, Sayers RD. The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneurysms: A case-control study. J Vasc Surg 2003;37:999-1005. (Pubitemid 36538922)
10. Donger C, Georges JL, Nicaud V, Morrison C, Evans A, Kee F, et al. New polymorphisms in the interleukin-10 gene-Relationships to myocardial infarction. Eur J Clin Invest 2001;31:9-14.
11. Fragoso JM, Vallejo M, Alvarez-León E, Delgadillo H, Peña-Duque MA, Cardoso-Saldaña G, et al. Alleles and haplotypes of the interleukin 10 gene polymorphisms are associated with risk of developing acute coronary syndrome in Mexican patients. Cytokine 2011;55:29-33.
12. George S, Ruan XZ, Navarrete C, Turner D, Reynard M, Sweny P, et al. Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10. Tissue Antigens 2004;63:470-5. (Pubitemid 38648213)
13. Koch W, Kastrati A, Böttiger C, Mehilli J, von Beckerath N, Schömig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001;159:137-44. (Pubitemid 33016630)
14. Lio D, Candore G, Crivello A, Scola L, Colonna-Romano G, Cavallone L, et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: Genetic background of male centenarians is protective against coronary heart disease. J Med Genet 2004;41:790-4. (Pubitemid 39389298)
15. Lorenzová A, Stanek V, Gebauerová M, Bohuslavová R, Stávek P, Hubácek JA, et al. High-sensitivity C-reactive protein concentration in patients with myocardial infarction-environmental factors, and polymorphisms in interleukin-10 and CD14 genes. Clin Chem Lab Med 2007;45:855-61. (Pubitemid 47041899)
16. Marousi S, Ellul J, Antonacopoulou A, Gogos C, Papathanasopoulos P, Karakantza M. Functional polymorphisms of interleukin 4 and interleukin 10 may predict evolution and functional outcome of an ischaemic stroke. Eur J Neurol 2011;18:637-43.
17. Munshi A, Rajeshwar K, Kaul S, Al-Hazzani A, Alshatwi AA, Sai Babu M, et al. Interleukin-10-1082 promoter polymorphism and ischemic stroke risk in a South Indian population. Cytokine 2010;52:221-4.
18. Babu BM, Reddy BP, Priya VH, Munshi A, Rani HS, Latha GS, et al. Cytokine gene polymorphisms in the susceptibility to acute coronary syndrome. Genet Test Mol Biomarkers 2012;16:359-65.
19. Tuttolomondo A, Di Raimondo D, Forte GI, Casuccio A, Vaccarino L, Scola L, et al. Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti- inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine 2012;58:398-405.
20. Yu GI, Cho HC, Cho YK, Park HS, Yoon HJ, Kim HS, et al. Association of promoter region single nucleotide polymorphisms at positions-819C/ T and-592C/A of interleukin 10 gene with ischemic heart disease. Inflamm Res 2012;61:899-905.
21. Jin L, Ni P, Wu J, Fu Y, Ge H. The correlation between gene polymorphism of IL-10-819 C/T and-1082 G/A and cerebral infarction. Lab Med 2011;26:717-21.
22. Lin K. Study on the relationship between interleukin-10 gene polymorphisms and cerebral infarction, Fujian Medical University, 2009. Available from: Http://www.d.wanfangdata.com.cn/Thesis-Y1487152. aspx.
23. Wang J, Chen Z, Ma G. Relationship bewteen interleukin-10 gene-1082G/A,-819C/T polymorphism and premuture coronary heart disease. J Clin Cardiol 2007;23:3-6.
24. Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992;148:3618-23.
25. Turner DM1, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8. (Pubitemid 27050850)
26. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 1998;95:9465-70. (Pubitemid 28506254)